1-3 of 3
aids-related primary cns lymphoma
Close
Sort by
Journal Articles

Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate

Kathryn Lurain, MD MPH, Thomas S. Uldrick, MD MS, Priscila H. Goncalves, MD, Ramya Ramaswami, MBBS, MPH, Mark N. Polizzotto, Anaida Widell, Seth M. Steinberg, PhD, Elaine S. Jaffe, Stefania Pittaluga, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Richard F. Little, MD MPH, Robert Yarchoan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2963.
https://doi.org/10.1182/blood-2018-99-112169
Published: 2018
Journal Articles

High-Dose Methotrexate Is Effective, Safe, and Leads To Durable Responses In Patients With AIDS-Related Primary Central Nervous System Lymphoma Treated During The Era Of Combined Anti-Retroviral Therapy

Neel K. Gupta, MD, Jimmy Hwang, Ph.D., James L. Rubenstein, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1792.
https://doi.org/10.1182/blood.V122.21.1792.1792
Published: 2013
Journal Articles

Whole Brain Radiation Alone Brings the Favorable Outcomes for AIDS Related Primary Central Nervous System Lymphoma (PCNSL) Especially with Good Performance Status in the HAART Era.

Hirokazu Nagai, MD, Takashi Odawara, MD, Atsushi Ajisawa, MD, Shotaro Hagiwara, MD, Tomoko Uehira, MD, Hideki Uchiumi, MD, Mihoko Yotsumoto, MD, Toshikazu Miyakawa, MD, Akira Watanabe, MD, Mitsuru Konishi, MD, Seiji Saito, MD, Souichirou Takahama, MD, Masao Tateyama, MD, Seiji Okada, MD
Journal: Blood
Blood (2009) 114 (22): 4751.
https://doi.org/10.1182/blood.V114.22.4751.4751
Published: 2009